Tradestie Institutional Equity Comparison Engine
TERN vs DSGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TERN Overall Edge
TERN Captures Institutional Edge (3โ0 Pillars ยท 5โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Terns Pharmaceuticals, Inc. Common Stock (TERN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TERN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TERN sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TERN N/M vs DSGN N/M Fwd P/E
Growth & Margin Winner
TERN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
TERN
1Y +1387.4% vs +40.8% ยท 52W Pos 100% vs 30%
Options & Structure Winner
TERN
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (13th %ile IV)
TERN
NASDAQ
Terns Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$52.95
+0.04% 1D
Market Cap
$6.1B
1M Return
+0.44%
1Y Return
+1387.36%
Forward P/E
N/M
Unified AI Score
51.9 / 100
HOLD
Tech 40.0
Fund 42.0
Flow 60.0
Mom 21.1
DSGN
NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap
$677.5M
1M Return
-3.59%
1Y Return
+40.79%
Forward P/E
N/M
Unified AI Score
49.8 / 100
HOLD
Tech 55.0
Fund 57.0
Flow 63.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TERN +1387.36%
DSGN +40.79%
Spread: +68.89 pp (TERN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TERN TTM Op. Margin: 0.0%
DSGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TERN vs DSGN. Trailing 12-month operating profitability (TERN 0.0% vs DSGN 0.0%) and valuation multiples (TERN N/M vs DSGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TERN | DSGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1B | $677.5M | Larger Scale | TERN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -14.2% | -36.9% | Higher ROE | TERN |
| 52-Week Range Position Momentum | 100% ($3โ$53) | 30% ($7โ$17) | Stronger Trend | TERN |
| Beta / 30D Volatility Risk Regime | 0.07ฮฒ ยท 2% Vol | 1.32ฮฒ ยท 61% Vol | Lower Realized Risk | TERN |
| Unified Institutional Score Composite Signal | 51.9 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | TERN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TERN vs DSGN Buy Guide
TERN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
DSGN
BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TERN nor DSGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.